Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

pharmafile_autumn_2018

The Autumn 2018 edition of Pharmafile is available to read online now!

December 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunology, infectious diseases, pharma, pharmafile, rare diseases

The Autumn 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …
News
msd

MSD announced collaboration with Brazilian non-profit over development of dengue vaccine

December 13, 2018 Business Services, Medical Communications, Research and Development Dengue fever, HPV, hepatitis a, vaccines, virus

US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing …
News
yorkshire_moors_dales_yorkshire_landscape_england_countryside_english_rural-497670

Those living in rural areas less likely to survive cancer, study shows

December 13, 2018 Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban

Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research …
News

Government choose England top pharmacist to address overprescribing and polypharmacy

December 13, 2018 Medical Communications, Research and Development England, Matt Hancock, NHS, medicine, pharma

England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS. The move …
News

NICE reject two treatments for fatal, ultra-rare disease – hATTR

December 13, 2018 Medical Communications, Research and Development, Sales and Marketing

The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (hATTR), over …
News
pharmafocus_dec_2018_cover

The December issue of Pharmafocus is available to read online now!

December 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma

The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …
News

FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone

December 12, 2018 Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma

Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …
News
daphne_karydas

Allergan strengthens Finance Leadership Team with two appointments

December 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, MIT, Regeneron, appointment, pharma

The Dublin-headquartered multinational Allergan has appointed two experienced pharma investors to its Finance Leadership Team. The biopharmaceutical firm yesterday announced …
Appointment
the_registered_head_office_of_santen_pharmaceutical_co

Scottish Medicines Consortium approves Verkazia for severe eye condition in children and adolescents

December 12, 2018 Research and Development, Sales and Marketing SMC, Santen, Scotland, UK, Verkazia, pharma, vernal keratoconjunctivitis

UK-based pharmaceutical firm Santen has announced that the Scottish Medicines Consortium has awarded approval to its eye drops emulsion Verkazia …
News
amgen_flag

Amgen donate $2m towards increasing diversity in clinical trials

December 12, 2018 Research and Development Amgen, USA, clinical trials, diversity, donation

American multinational Amgen has teamed up with the Lazarex Cancer Foundation in support of an initiative aimed at increasing access …
News

Atopic dermatitis market set to almost triple in value over next 10 years

December 12, 2018 Research and Development atopic dermatitis, eczema, global data, markets, money

The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData. The market …
News

Tech platform company WuXi Biologics inks deal with cancer specialist Oxford BioTherapeutics worth $450m

December 12, 2018 Research and Development Cancer, Oxford Biotherapeutics, WuXi Biologics, alliance, deal, oncology

Clinical stage oncology firm Oxford BioTherapeutics has signed a deal with the open-access biologics technology platform company WuXi Biologics, in …
News

Woodley Equipment Company Acquires Blinded Diagnostics

December 11, 2018 Research and Development POCT, Point of Care Testing, clinical research, clinical trials, point-of-care testing

HORWICH, BOLTON Dec1 2018: Woodley Equipment Company Inc, a leading global supplier of rental equipment for use in Clinical Trials …
News
Press release
ben_osborne

Pfizer announces new UK Managing Director

December 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales

New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026